A bio-inspired cell-free system for cannabinoid production from inexpensive inputs

Abstract

Moving cannabinoid production away from the vagaries of plant extraction and into engineered microbes could provide a consistent, purer, cheaper and environmentally benign source of these important therapeutic molecules, but microbial production faces notable challenges. An alternative to microbes and plants is to remove the complexity of cellular systems by employing enzymatic biosynthesis. Here we design and implement a new cell-free system for cannabinoid production with the following features: (1) only low-cost inputs are needed; (2) only 12 enzymes are employed; (3) the system does not require oxygen and (4) we use a nonnatural enzyme system to reduce ATP requirements that is generally applicable to malonyl-CoA-dependent pathways such as polyketide biosynthesis. The system produces ~0.5 g l−1 cannabigerolic acid (CBGA) or cannabigerovarinic acid (CBGVA) from low-cost inputs, nearly two orders of magnitude higher than yeast-based production. Cell-free systems such as this may provide a new route to reliable cannabinoid production.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1: Cannabinoid biosynthesis.
Fig. 2: Cell-free system design for cannabinoid production.
Fig. 3: Testing the AP module and MatB system.
Fig. 4: System testing.
Fig. 5: Implementation of the full cannabinoid production system.

Data availability

Data will be made available upon request. Materials will be made available with applicable material transfer agreement.

References

  1. 1.

    Turner, S. E., Williams, C. M., Iversen, L. & Whalley, B. J. Molecular pharmacology of phytocannabinoids. Prog. Chem. Org. Nat. Prod. 103, 61–101 (2017).

    CAS  PubMed  Google Scholar 

  2. 2.

    Schrot, R. J. & Hubbard, J. R. Cannabinoids: medical implications. Ann. Med. 48, 128–141 (2016).

    CAS  Article  Google Scholar 

  3. 3.

    Vučković, S., Srebro, D., Vujović, K. S., Vučetić, Č. & Prostran, M. Cannabinoids and pain: new insights from old molecules. Front Pharm. 9, 1259–1259 (2018).

    Article  Google Scholar 

  4. 4.

    Scherma, M. et al. New perspectives on the use of cannabis in the treatment of psychiatric disorders. Medicines 5, 107 (2018).

    CAS  Article  Google Scholar 

  5. 5.

    Wargent, E. T. et al. The cannabinoid Δ(9)-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity. Nutr. Diabetes 3, e68–e68 (2013).

    CAS  Article  Google Scholar 

  6. 6.

    Zamberletti, E. et al. Cannabidivarin treatment ameliorates autism-like behaviors and restores hippocampal endocannabinoid system and glia alterations induced by prenatal valproic acid exposure in rats. Front. Cell. Neurosci. 13, 367 (2019).

    CAS  Article  Google Scholar 

  7. 7.

    Carvalho, Â., Hansen, E. H., Kayser, O., Carlsen, S. & Stehle, F. Designing microorganisms for heterologous biosynthesis of cannabinoids. FEMS Yeast Res. 17, fox037 (2017).

  8. 8.

    Luo, X. et al. Complete biosynthesis of cannabinoids and their unnatural analogues in yeast. Nature 567, 123–126 (2019).

    CAS  Article  Google Scholar 

  9. 9.

    ElSohly, M. A., Radwan, M. M., Gul, W., Chandra, S. & Galal, A. Phytochemistry of Cannabis sativa L. in Phytocannabinoids: Unraveling the Complex Chemistry and Pharmacology of Cannabis sativa (eds. Kinghorn, A. D., Falk, H., Gibbons, S. & Kobayashi, J.) 1–36 (Springer International Publishing, 2017); https://doi.org/10.1007/978-3-319-45541-9_1

  10. 10.

    Dolgin, E. The bioengineering of cannabis. Nature 572, S5–S7 (2019).

    CAS  Article  Google Scholar 

  11. 11.

    Degenhardt, F., Stehle, F. & Kayser, O. in Handbook of Cannabis and Related Pathologies (ed. Preedy, V. R.) Ch. 2, 13–23 (Academic Press, 2017); https://doi.org/10.1016/B978-0-12-800756-3.00002-8

  12. 12.

    Keasling, J. D. Synthetic biology and the development of tools for metabolic engineering. Metab. Eng. 14, 189–195 (2012).

    CAS  Article  Google Scholar 

  13. 13.

    Hodgman, C. E. & Jewett, M. C. Cell-free synthetic biology: thinking outside the cell. Metab. Eng. 14, 261–269 (2012).

    CAS  Article  Google Scholar 

  14. 14.

    Kwok, R. Five hard truths for synthetic biology. Nature 463, 288–290 (2010).

    CAS  Article  Google Scholar 

  15. 15.

    Ricca, E., Brucher, B. & Schrittwieser, J. H. Multi-enzymatic cascade reactions: overview and perspectives. Adv. Synth. Catal. 353, 2239–2262 (2011).

    CAS  Article  Google Scholar 

  16. 16.

    Huffman, M. A. et al. Design of an in vitro biocatalytic cascade for the manufacture of islatravir. Science 366, 1255–1259 (2019).

    CAS  Article  Google Scholar 

  17. 17.

    Valliere, M. A. et al. A cell-free platform for the prenylation of natural products and application to cannabinoid production. Nat. Commun. 10, 565 (2019).

    CAS  Article  Google Scholar 

  18. 18.

    Garcia-Ochoa, F. & Gomez, E. Bioreactor scale-up and oxygen transfer rate in microbial processes: an overview. Biotechnol. Adv. 27, 153–176 (2009).

    CAS  Article  Google Scholar 

  19. 19.

    Lund, S., Hall, R. & Williams, G. J. An Artificial pathway for isoprenoid biosynthesis decoupled from native hemiterpene metabolism. ACS Synth. Biol. 8, 232–238 (2019).

    CAS  Article  Google Scholar 

  20. 20.

    Chatzivasileiou, A. O., Ward, V., Edgar, S. M. & Stephanopoulos, G. Two-step pathway for isoprenoid synthesis. Proc. Natl Acad. Sci. USA 116, 506–511 (2019).

    CAS  Article  Google Scholar 

  21. 21.

    Ward, V. C. A., Chatzivasileiou, A. O. & Stephanopoulos, G. Cell free biosynthesis of isoprenoids from isopentenol. Biotechnol. Bioeng. 116, 3269–3281 (2019).

    CAS  Article  Google Scholar 

  22. 22.

    Crans, D. C. & Whitesides, G. M. A convenient synthesis of disodium acetyl phosphate for use in in situ ATP cofactor regeneration. J. Org. Chem. 48, 3130–3132 (1983).

    CAS  Article  Google Scholar 

  23. 23.

    Gagne, S. J. et al. Identification of olivetolic acid cyclase from Cannabis sativa reveals a unique catalytic route to plant polyketides. Proc. Natl Acad. Sci. USA 109, 12811–12816 (2012).

    CAS  Article  Google Scholar 

  24. 24.

    Taura, F. et al. Characterization of olivetol synthase, a polyketide synthase putatively involved in cannabinoid biosynthetic pathway. FEBS Lett. 583, 2061–2066 (2009).

    CAS  Article  Google Scholar 

  25. 25.

    Tan, Z., Clomburg, J. M. & Gonzalez, R. Synthetic pathway for the production of olivetolic acid in Escherichia coli. ACS Synth. Biol. 7, 1886–1896 (2018).

    CAS  Article  Google Scholar 

  26. 26.

    Flamholz, A., Noor, E., Bar-Even, A. & Milo, R. eQuilibrator—the biochemical thermodynamics calculator. Nucleic Acids Res. 40, D770–D775 (2012).

    CAS  Article  Google Scholar 

  27. 27.

    Chohnan, S., Akagi, K. & Takamura, Y. Functions of malonate decarboxylase subunits from Pseudomonas putida. Biosci. Biotechnol., Biochem. 67, 214–217 (2003).

    CAS  Article  Google Scholar 

  28. 28.

    Koo, J. H. & Kim, Y. S. Functional evaluation of the genes involved in malonate decarboxylation by Acinetobacter calcoaceticus. Eur. J. Biochem. 266, 683–690 (1999).

    CAS  Article  Google Scholar 

  29. 29.

    Stout, J. M., Boubakir, Z., Ambrose, S. J., Purves, R. W. & Page, J. E. The hexanoyl-CoA precursor for cannabinoid biosynthesis is formed by an acyl-activating enzyme in Cannabis sativa trichomes. Plant J. 71, 353–365 (2012).

    CAS  PubMed  Google Scholar 

  30. 30.

    Peters, Jnr, T. All About Albumin: Biochemistry, Genetics, and Medical Applications (Academic Press, 1995).

  31. 31.

    Zielinski, K., Sekula, B., Bujacz, A. & Szymczak, I. Structural investigations of stereoselective profen binding by equine and leporine serum albumins. Chirality 32, 334–344 (2020).

    CAS  Article  Google Scholar 

  32. 32.

    Bowie, J. U. et al. Synthetic biochemistry: the bio-inspired cell-free approach to commodity chemical production. Trends Biotechnol. 38, 766–778 (2020).

    CAS  Article  Google Scholar 

  33. 33.

    Kearsey, L. J. et al. Structure of the Cannabis sativa olivetol-producing enzyme reveals cyclization plasticity in type III polyketide synthases. FEBS J. 287, 1511–1524 (2020).

    CAS  Article  Google Scholar 

  34. 34.

    Korman, T. P., Opgenorth, P. H. & Bowie, J. U. A synthetic biochemistry platform for cell free production of monoterpenes from glucose. Nat. Commun. 8, 15526 (2017).

    CAS  Article  Google Scholar 

  35. 35.

    Goldenzweig, A. et al. Automated structure- and sequence-based design of proteins for high bacterial expression and stability. Mol. Cell 70, 380 (2018).

    CAS  Article  Google Scholar 

  36. 36.

    Shoyama, Y., Hirano, H., Makino, H., Umekita, N. & Nishioka, I. Cannabis X: the isolation and structures of four new propyl cannabinoid acids, tetrahydrocannabivarinic acid, cannabidivarinic acid, cannabichromevarinic acid and cannabigerovarinic acid, from Thai cannabis, ‘Meao variant’. Chem. Pharm. Bull. 25, 2306–2311 (1977).

    CAS  Article  Google Scholar 

Download references

Acknowledgements

This work was supported by Department of Energy grant nos. DE-FC02-02ER63421 and DE-AR0000556 to J.U.B.

Author information

Affiliations

Authors

Contributions

M.A.V. developed system designs in consultation with T.P.K. and J.U.B. All authors contributed to experimental design and data analysis, but M.A.V. designed the bulk of the experiments. M.A.V. also conducted the bulk of the experiments with assistance from T.P.K. and M.A.A. M.A.V. and J.U.B. wrote the manuscript with contributions from T.P.K. and M.A.A.

Corresponding author

Correspondence to James U. Bowie.

Ethics declarations

Competing interests

J.U.B. and T.P.K. have founded a company Invizyne Technologies, Inc. to develop cell-free production methods. M.A.V. is also a stockholder.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Extended data

Extended Data Fig. 1 The effect of OLS and AAE3 concentrations on product specificity.

The concentration of CsOLS vs Product Specificity is plotted at three different AAE3 concentrations. As the concentration of CsOLS or CsAAE3 increase, we observe a decrease in product specificity. Total Peak Area is calculated as the sum of all peaks that appear in the HPLC trace due to the activity of OLS and AAE3. The data points reflect the mean and the error bars represent standard deviation of biological replicates.

Extended Data Fig. 2 OA inhibition of enzyme activity.

The remaining activity in the presence of 5 mM OA (teal bars) or 0.25 mM OA (blue bars). The bar heights reflect the mean and the error bars represent standard deviation of biological replicates. The results of each experiment are shown by the open circles.

Extended Data Fig. 3 Inhibition of OA and CBGA production by GPP.

The RpMatB reaction system was used to generate OA, which can then be prenylated by the added GPP, catalyzed by NphBM31S. We observe that increasing GPP leads to a decrease in overall production of OA and CBGA, indicating that GPP inhibits the OA pathway. The data points reflect the mean and the error bars represent standard deviation of biological replicates. The error bars are hidden by the data points in this plot.

Extended Data Fig. 4 Stabilization of NphB M31.

Activity remaining after a 20 min incubation at various temperatures is shown for the parent enzyme NphB M31 and the new enzyme NphB M31s. The data points reflect the mean and the error bars represent standard deviation of biological replicates.

Extended Data Fig. 5 Thermal Inactivation of MdcA from Pseudomonas putida Geobacillus stearothermophilus.

Activity remaining after a 20 min incubation at various temperatures is shown. The solvent conditions were 0.45 mg/ml P. putida MdcA (black) or 0.37 mg/ml enzyme G. stearothermophlus MdcA (blue) in 50 mM Tris [pH 8.0], 150 mM NaCl, 250 mM Imidizole, 30% glycerol. The data points reflect the mean and the error bars represent standard deviation of biological replicates.

Extended Data Fig. 6 The titer of CBGA as a function of initial AcP concentrations.

We chose to proceed with 50 mM initial AcP because increasing the AcP concentration over 50 mM decreases the CBGA titer. The data points reflect the mean and the error bars represent standard deviation of biological replicates.

Extended Data Fig. 7 The effect of BSA on the titer of OA using MdcA to generate malonyl-CoA.

BSA titration data showing 20 mg/mL BSA should be used in subsequent reactions because there was minimal improvement when BSA was increased to 40 mg/mL. The data points reflect the mean and the error bars represent standard deviation of biological replicates.

Extended Data Fig. 8 The effect of acetate and phosphate on CBGA production.

Varying starting Acetate or Phosphate concentration from 0 to 100 mM had minimal effect on CBGA production using isoprenol and OA as inputs. The data points reflect the mean and the error bars represent standard deviation of biological replicates.

Supplementary information

Supplementary Information

Supplementary Table 1 and Note

Reporting Summary

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Valliere, M.A., Korman, T.P., Arbing, M.A. et al. A bio-inspired cell-free system for cannabinoid production from inexpensive inputs. Nat Chem Biol 16, 1427–1433 (2020). https://doi.org/10.1038/s41589-020-0631-9

Download citation

Search

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing